Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart

Sharon Chih1, Aun Yeong Chong2, Vladimír Džavík3

  • 1Heart Failure and Transplantation (S.C., E.S., L.M.M.), Division of Cardiology, University of Ottawa Heart Institute, ON, Canada.

Insights

Early identification of cardiac allograft vasculopathy (CAV) is crucial for heart transplant recipients. Fibrotic plaque and microvascular dysfunction in the first year predict CAV progression, guiding early intervention strategies.

Area of Science:

  • Cardiology
  • Transplantation Immunology
  • Vascular Biology

Background:

  • Cardiac allograft vasculopathy (CAV) impacts long-term heart transplant outcomes.
  • Early prognostication of CAV is essential for patient management.
  • Characterizing early post-transplant coronary changes can identify progression predictors.

Purpose of the Study:

  • To identify predictors of early cardiac allograft vasculopathy (CAV) progression.
  • To characterize coronary anatomic-physiologic alterations within the first year post-heart transplantation.
  • To establish early markers for improved long-term heart transplant outcomes.

Main Methods:

  • Prospective evaluation of 82 heart transplant recipients at 3 and 12 months post-transplant.
  • Utilized angiography, intravascular ultrasound, optical coherence tomography, and coronary physiology assessments.
  • Assessed CAV progression via intravascular ultrasound change in percentage intimal volume.

Main Results:

  • Donor atherosclerosis was present in 50% at baseline.
  • De novo or rapidly progressive CAV developed in 24% and 13% of patients, respectively.
  • Fibrotic plaque increased from 29% to 50%; microvascular dysfunction (IMR ≥25) was seen in 20% of patients. Recipient male sex, fibrotic plaque, and IMR independently predicted coronary disease progression.

Conclusions:

  • Fibrotic plaque identified by optical coherence tomography predicts CAV progression.
  • Index of microcirculatory resistance (IMR) early post-transplant is a predictor of CAV progression.
  • These markers can aid in early prognostication and management of CAV.
Abstract

Related Concept Videos